Carroll B. Leevy
About
In The Last Decade
Carroll B. Leevy
29 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Epidemiology 921
- Hepatology 920
- Surgery 599
- Molecular Biology 150
- Pharmacology 82
Countries citing papers authored by Carroll B. Leevy
This map shows the geographic impact of Carroll B. Leevy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carroll B. Leevy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carroll B. Leevy more than expected).
Fields of papers citing papers by Carroll B. Leevy
This network shows the impact of papers produced by Carroll B. Leevy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carroll B. Leevy. The network helps show where Carroll B. Leevy may publish in the future.
Co-authorship network of co-authors of Carroll B. Leevy
This figure shows the co-authorship network connecting the top 25 collaborators of Carroll B. Leevy. A scholar is included among the top collaborators of Carroll B. Leevy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carroll B. Leevy. Carroll B. Leevy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Rifaximin Treatment in Hepatic Encephalopathy breakdown → | 848 |
| 2 | Viral hepatitis in Hawai'i--differing perspectives. | 1 |
| 3 | 20 | |
| 4 | 122 | |
| 5 | 38 | |
| 6 | 21 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 54 | |
| 10 | 10 | |
| 11 | 24 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | Clearance of indocyanine green in the evaluation of liver donors. | 23 |
| 15 | 1 | |
| 16 | 6 | |
| 17 | 5 | |
| 18 | Use of a specific monoclonal antibody to detect Mallory bodies in liver disease. | 2 |
| 19 | 9 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.